Chemotherapy

News

02.02.2023

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Insider Insights

02.02.2023

NICE has recommended the first CAR T-cell therapy, Yescarta for the treatment of some lymphomas in a...

Case Studies

01.01.2023

Identification of current cost of oncology care treatment options.

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

First Name(Required)

Last Name(Required)

Email Address(Required)

Phone(Required)

This field is hidden when viewing the form

Job Title(Required)

Which category are you most interested in receiving content on?(Required)

Consent

I agree to be contacted with relevant content and news

Comments

This field is for validation purposes and should be left unchanged.

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.

Remap Consulting GmbH
Industriestrasse 47
Postfach 7461
6302 Zug
Switzerland

Remap Consulting UK Ltd
1F43, Mereside
Alderley Park
Cheshire
SK10 4TG